Medication
There are no medications that specifically treat Asperger's syndrome. But some medications may improve specific symptoms — such as anxiety, depression or hyperactivity — that can occur in many children with Asperger's syndrome. Examples include:
Aripiprazole (Abilify). This drug may be effective for treating irritability related to Asperger's syndrome. Side effects may include weight gain and an increase in blood sugar levels.
Guanfacine (Intuniv). This medication may be helpful for the problems of hyperactivity and inattention in children with Asperger's syndrome. Side effects may include drowsiness, irritability, headache, constipation and bedwetting.
Selective serotonin reuptake inhibitors (SSRIs). Drugs such as
fluvoxamine (Luvox) may be used to treat depression or to help control repetitive behaviors. Possible side effects include restlessness and agitation.
Risperidone (Risperdal). This medication may be prescribed for agitation and irritability. It may cause trouble sleeping, a runny nose and an increased appetite. This drug has also been associated with an increase in cholesterol and blood sugar levels.
Olanzapine (Zyprexa). Olanzapine is sometimes prescribed to reduce repetitive behaviors. Possible side effects include increased appetite, drowsiness, weight gain, and increased blood sugar and cholesterol levels.
Naltrexone (Revia). This medication, which is sometimes used to help alcoholics stop drinking, may help reduce some of the repetitive behaviors associated with Asperger's syndrome. However, the use of low-dose naltrexone — in doses as low as two to four mg a day — has been gaining favor recently. But, there's no good evidence that such low doses have any effect on Asperger's syndrome.
Alternative medicine Tests and diagnosis
References
Asperger's disorder. In: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. Arlington, Va.: American Psychiatric Association; 2000.
http://psychiatryonline.com/content.aspx?aID=7667&searchStr=asperger's+disorder. Accessed Sept. 10, 2010.
Toth K, et al. Asperger's syndrome: Diagnosis and treatment. American Journal of Psychiatry. 2008;165:958.
Autism spectrum disorders. The Merck Manuals: The Merck Manual for Healthcare Professionals.
http://www.merck.com/mmpe/sec19/ch299/ch299c.html#S19_CH299_T002. Accessed Sept. 11, 2010.
Asperger syndrome fact sheet. National Institute of Neurological Disorders and Stroke.
http://www.ninds.nih.gov/disorders/asperger/detail_asperger.htm?css=print. Accessed Sept 11, 2010.
Notordaeme M, et al. Asperger's syndrome and high-functioning autism: Language, motor and cognitive profiles. European Child and Adolescent Psychiatry. 2010;19:475.
Asperger syndrome. National Institute of Child Health and Human Development.
http://www.nichd.nih.gov/health/topics/asperger_syndrome.cfm. Accessed Sept. 11, 2010.
Weber K. Asperger's syndrome: From hiding to thriving. The Nurse Practitioner. 2008;19:14.
Levy SE, et al. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child and Adolescent Psychiatry Clinics of North America. 2008;17:803.
Price CS, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics. 2010;126:656.
Atkinson DL (expert opinion). Mayo Clinic, Rochester, Minn. Oct. 25, 2010.
Stigler KA, et al. Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: A 14-week, perspective, open-label study. Journal of Child and Adolescent Psychopharmacology. 2009;19:265.
Posey DJ, et al. Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: A retrospective analysis of 80 cases. Journal of Child and Adolescent Psychopharmacology. 2004;14:233.
Moreno C, et al. Metabolic effects of second-generation antipsychotics in bipolar youth: Comparison with other psychotic and nonpsychotic diagnoses. Bipolar Disorders. 2010;12:172.
Malone RP, et al. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders. CNS Drugs. 2005;19:923.
Elchaar GM, et al. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder. Annals of Pharmacotherapy. 2006;40:1086.
Questions and answers on unapproved chelation products. Food and Drug Administration.
http://www.fda.gov/Drugs/ResourcesF...ineSafely/MedicationHealthFraud/ucm229313.htm. Accessed Oct. 26, 2010.
Guastella AJ, et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biological Psychiatry. 2010;67:692.
Hollander E, et al. Oxytocin increases retention of social cognition in autism. Biological Psychiatry. 2007;61:498.
DS00551
Nov. 18, 2010
© 1998-2010 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.